[DPHARMA] QoQ TTM Result on 31-Mar-2024 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
23-May-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
31-Mar-2024 [#1]
Profit Trend
QoQ- -13.97%
YoY- -37.49%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 697,220 704,727 689,186 697,025 711,251 696,717 690,201 0.67%
PBT 55,077 63,268 71,581 81,539 86,497 84,851 86,632 -26.04%
Tax -9,787 -10,622 -10,276 -12,855 -14,043 -14,739 -17,965 -33.27%
NP 45,290 52,646 61,305 68,684 72,454 70,112 68,667 -24.20%
-
NP to SH 45,290 52,646 61,305 68,684 72,454 70,112 68,667 -24.20%
-
Tax Rate 17.77% 16.79% 14.36% 15.77% 16.24% 17.37% 20.74% -
Total Cost 651,930 652,081 627,881 628,341 638,797 626,605 621,534 3.23%
-
Net Worth 682,979 682,979 673,359 670,448 666,567 657,045 647,522 3.61%
Dividend
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Div 22,103 22,103 21,929 21,929 21,874 21,874 21,685 1.27%
Div Payout % 48.81% 41.99% 35.77% 31.93% 30.19% 31.20% 31.58% -
Equity
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Net Worth 682,979 682,979 673,359 670,448 666,567 657,045 647,522 3.61%
NOSH 961,942 961,942 961,942 961,942 952,239 952,239 952,239 0.67%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 6.50% 7.47% 8.90% 9.85% 10.19% 10.06% 9.95% -
ROE 6.63% 7.71% 9.10% 10.24% 10.87% 10.67% 10.60% -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 72.48 73.26 71.65 72.77 74.69 73.17 72.48 0.00%
EPS 4.71 5.47 6.37 7.17 7.61 7.36 7.21 -24.69%
DPS 2.30 2.30 2.30 2.30 2.30 2.30 2.28 0.58%
NAPS 0.71 0.71 0.70 0.70 0.70 0.69 0.68 2.91%
Adjusted Per Share Value based on latest NOSH - 961,942
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 72.48 73.26 71.65 72.46 73.94 72.43 71.75 0.67%
EPS 4.71 5.47 6.37 7.14 7.53 7.29 7.14 -24.20%
DPS 2.30 2.30 2.30 2.28 2.27 2.27 2.25 1.47%
NAPS 0.71 0.71 0.70 0.697 0.6929 0.683 0.6731 3.61%
Price Multiplier on Financial Quarter End Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 -
Price 1.20 1.26 1.20 1.30 1.56 1.61 1.30 -
P/RPS 1.66 1.72 1.67 1.79 2.09 2.20 1.79 -4.89%
P/EPS 25.49 23.02 18.83 18.13 20.50 21.87 18.03 25.93%
EY 3.92 4.34 5.31 5.52 4.88 4.57 5.55 -20.67%
DY 1.92 1.83 1.92 1.77 1.47 1.43 1.75 6.36%
P/NAPS 1.69 1.77 1.71 1.86 2.23 2.33 1.91 -7.82%
Price Multiplier on Announcement Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 23/05/24 22/02/24 08/11/23 24/08/23 22/05/23 23/02/23 09/11/22 -
Price 1.26 1.21 1.22 1.19 1.44 1.65 1.39 -
P/RPS 1.74 1.65 1.70 1.64 1.93 2.26 1.92 -6.34%
P/EPS 26.76 22.11 19.14 16.59 18.93 22.41 19.28 24.40%
EY 3.74 4.52 5.22 6.03 5.28 4.46 5.19 -19.60%
DY 1.83 1.90 1.89 1.93 1.60 1.39 1.64 7.57%
P/NAPS 1.77 1.70 1.74 1.70 2.06 2.39 2.04 -9.02%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment